ATE476179T1 - Kombination aus triazinderivaten und insulin- sensibilisatoren - Google Patents
Kombination aus triazinderivaten und insulin- sensibilisatorenInfo
- Publication number
- ATE476179T1 ATE476179T1 AT06829706T AT06829706T ATE476179T1 AT E476179 T1 ATE476179 T1 AT E476179T1 AT 06829706 T AT06829706 T AT 06829706T AT 06829706 T AT06829706 T AT 06829706T AT E476179 T1 ATE476179 T1 AT E476179T1
- Authority
- AT
- Austria
- Prior art keywords
- combination
- triazine derivatives
- insulin sensitizers
- sensitizers
- insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0600344A FR2896159B1 (fr) | 2006-01-13 | 2006-01-13 | Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline. |
PCT/EP2006/012185 WO2007079917A2 (en) | 2006-01-13 | 2006-12-18 | Combination of triazine derivatives and insulin sensitisers |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE476179T1 true ATE476179T1 (de) | 2010-08-15 |
Family
ID=36654309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06829706T ATE476179T1 (de) | 2006-01-13 | 2006-12-18 | Kombination aus triazinderivaten und insulin- sensibilisatoren |
Country Status (22)
Country | Link |
---|---|
US (2) | US8791115B2 (de) |
EP (1) | EP1971330B1 (de) |
JP (1) | JP5249782B2 (de) |
KR (2) | KR20140033498A (de) |
CN (1) | CN101355933A (de) |
AR (1) | AR059032A1 (de) |
AT (1) | ATE476179T1 (de) |
AU (1) | AU2006334734B2 (de) |
BR (1) | BRPI0620985B8 (de) |
CA (1) | CA2640897C (de) |
CY (1) | CY1110789T1 (de) |
DE (1) | DE602006016014D1 (de) |
DK (1) | DK1971330T3 (de) |
EA (1) | EA015576B1 (de) |
ES (1) | ES2347177T3 (de) |
FR (1) | FR2896159B1 (de) |
IL (1) | IL192558A (de) |
PL (1) | PL1971330T3 (de) |
PT (1) | PT1971330E (de) |
SI (1) | SI1971330T1 (de) |
WO (1) | WO2007079917A2 (de) |
ZA (1) | ZA200806947B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2896159B1 (fr) * | 2006-01-13 | 2008-09-12 | Merck Sante Soc Par Actions Si | Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline. |
SI2355829T1 (sl) * | 2008-12-12 | 2015-03-31 | Poxel S.A.S. | Kombinacija inzulina z derivati triazina in njegova uporaba za zdravljenje diabetesa |
AU2009326965A1 (en) * | 2008-12-12 | 2011-06-23 | Poxel | Tetrahydrotriazine compounds for treating diseases associated with AMPK activity |
FR2948026B1 (fr) * | 2009-07-17 | 2011-12-02 | Merck Sante Sas | Derives amines de dihydro-1,3,5-triazine |
FR2948027A1 (fr) * | 2009-07-17 | 2011-01-21 | Merck Sante Sas | Derives amines de dihydro-1,3,5-triazine pour leur utilisation dans le traitement des maladies associees a une ischemie et/ou une reperfusion |
TWI436768B (zh) * | 2010-06-09 | 2014-05-11 | Poxel | 第2型糖尿病之治療 |
KR20120011667A (ko) * | 2010-07-29 | 2012-02-08 | 광주과학기술원 | 당뇨병 치료제의 스크리닝 방법 |
KR101271218B1 (ko) * | 2012-12-07 | 2013-06-07 | 광주과학기술원 | 당뇨병 치료제의 스크리닝 방법 |
KR20200102982A (ko) | 2017-10-02 | 2020-09-01 | 폭셀 | 보존된 박출률을 갖는 심부전의 치료 방법 |
MX2020013210A (es) | 2018-06-06 | 2021-02-26 | Metavant Sciences Gmbh | Metodos de tratamiento de sujetos que padecen diabetes con enfermedad renal cronica. |
JP7266616B2 (ja) | 2018-06-14 | 2023-04-28 | ポクセル | 糖尿病の治療において使用するためのトリアジン誘導体を含むフィルムコーティング錠剤 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6288095B1 (en) * | 1987-09-04 | 2001-09-11 | Beecham Group P.L.C. | Compounds |
US5885980A (en) * | 1996-06-25 | 1999-03-23 | Enrique G. Gutierrez | Composition and method for treating diabetes |
US6011049A (en) | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
TWI302149B (en) | 1999-09-22 | 2008-10-21 | Bristol Myers Squibb Co | Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method |
AR030920A1 (es) | 1999-11-16 | 2003-09-03 | Smithkline Beecham Plc | Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones |
FR2804113B1 (fr) * | 2000-01-26 | 2004-06-18 | Lipha | Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique |
ES2290130T3 (es) * | 2000-05-01 | 2008-02-16 | Aeropharm Technology, Llc | Formulacion de nucleo. |
FR2853650B1 (fr) * | 2003-04-10 | 2006-07-07 | Merck Sante Sas | Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance |
TW200526678A (en) * | 2003-08-01 | 2005-08-16 | Janssen Pharmaceutica Nv | Substituted indole-O-glucosides |
FR2863484B1 (fr) * | 2003-12-11 | 2007-04-13 | Oreal | Utilisation de composes capables d'agir sur la voie metabolique controlee par la dopachrome tautomerase trp-2 comme agent protecteur des melanocytes du follicule pileux et applications |
EP1841414A1 (de) * | 2003-12-31 | 2007-10-10 | Alpharma, Inc. | Rosiglitazon- und metformin-formulierungen |
FR2896159B1 (fr) * | 2006-01-13 | 2008-09-12 | Merck Sante Soc Par Actions Si | Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline. |
-
2006
- 2006-01-13 FR FR0600344A patent/FR2896159B1/fr not_active Expired - Fee Related
- 2006-12-18 EP EP06829706A patent/EP1971330B1/de active Active
- 2006-12-18 BR BRPI0620985A patent/BRPI0620985B8/pt not_active IP Right Cessation
- 2006-12-18 DE DE602006016014T patent/DE602006016014D1/de active Active
- 2006-12-18 DK DK06829706.8T patent/DK1971330T3/da active
- 2006-12-18 AU AU2006334734A patent/AU2006334734B2/en not_active Ceased
- 2006-12-18 CN CNA2006800509443A patent/CN101355933A/zh active Pending
- 2006-12-18 US US12/160,664 patent/US8791115B2/en active Active
- 2006-12-18 KR KR1020147002582A patent/KR20140033498A/ko not_active Application Discontinuation
- 2006-12-18 PT PT06829706T patent/PT1971330E/pt unknown
- 2006-12-18 KR KR20087019624A patent/KR101482685B1/ko active IP Right Grant
- 2006-12-18 PL PL06829706T patent/PL1971330T3/pl unknown
- 2006-12-18 WO PCT/EP2006/012185 patent/WO2007079917A2/en active Application Filing
- 2006-12-18 EA EA200801676A patent/EA015576B1/ru not_active IP Right Cessation
- 2006-12-18 JP JP2008549783A patent/JP5249782B2/ja active Active
- 2006-12-18 SI SI200630793T patent/SI1971330T1/sl unknown
- 2006-12-18 AT AT06829706T patent/ATE476179T1/de active
- 2006-12-18 CA CA2640897A patent/CA2640897C/en not_active Expired - Fee Related
- 2006-12-18 ES ES06829706T patent/ES2347177T3/es active Active
-
2007
- 2007-01-12 AR ARP070100138A patent/AR059032A1/es unknown
-
2008
- 2008-07-01 IL IL192558A patent/IL192558A/en active IP Right Grant
- 2008-08-12 ZA ZA200806947A patent/ZA200806947B/xx unknown
-
2010
- 2010-09-16 CY CY20101100840T patent/CY1110789T1/el unknown
-
2013
- 2013-10-25 US US14/063,530 patent/US20140050786A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE476179T1 (de) | Kombination aus triazinderivaten und insulin- sensibilisatoren | |
DE602007010981D1 (de) | Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate | |
DK1984322T3 (da) | Benzamid- og heteroarenderivater | |
DOP2007000084A (es) | Derivados de dihidropirazolopirimidinona | |
ATE531720T1 (de) | Aza-benzofuranylverbindungen und anwendungsverfahren dafür | |
ATE483711T1 (de) | Spiroindolinonderivate | |
ATE469905T1 (de) | Pyridopyrimidinonderivate | |
ATE512135T1 (de) | Spiroindolinonderivate | |
DOP2010000044A (es) | Derivado de oxopirazina y herbicida | |
DK2035394T3 (da) | 2-pyrazincarboxamidderivater | |
BRPI0819232A2 (pt) | composto heterocíclico e composição farmacêutica do mesmo | |
NO345064B1 (no) | Anvendelse av kombinasjonslegemidler, omfattende antimykotika | |
ATE511509T1 (de) | Azaindolylverbindungen und anwendungsverfahren | |
CR10562A (es) | Nuevos derivados de piridazina | |
ATE486076T1 (de) | 6-carboxy-normorphinan-derivate, ihre synthese und verwendung | |
ATE544752T1 (de) | Aryloxyacetamidderivate und ihre verwendung als fungizide | |
NO20091266L (no) | Fremgangsmåter for administrering av langvarige hypoglykemiske midler | |
ATE544764T1 (de) | 5-hydroxymethyloxazolidin-2-onderivate | |
ATE420081T1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
CR10809A (es) | Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona | |
BRPI0816992A2 (pt) | Derivado heterocíclico tricícloco, e, composição farmacêutica | |
ATE540682T1 (de) | Kombination von triazin-derivaten und insulin- sekretionsstimulatoren | |
ATE513817T1 (de) | Pyrimidinderivate und ihre verwendung als pestizide | |
BRPI0819202A2 (pt) | Derivado heterocíclico, e, composição farmacêutica | |
DK2043656T3 (da) | Hidtil ukendt medicinsk anvendelse af triazinderivater |